
Code Pharma BV: Antiviral Drug Codivir Shows Promising Effect Against COVID-19
Code Pharma , a Dutch pharmaceutical company, is developing a direct antiviral drug against COVID-19. Following the successful completion of a phase I study, the company is now initiating a phase II double-blind controlled study in Spain, Brazil, South Africa, and Israel. TEL AVIV, ISRAEL / DE BILT, NETHERLANDS - EQS Newswire - 1 September 2021 - Codivir, a short syntheti
read full article







